Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Identifying tumor-selective antigens like CDH17, GD2, and ...

Sagar Lonial, MD, discusses the expanding potential uses of cereblon E3 ligase modulators (CELMoDs) in combination with T-cell redirection therapies in multiple myeloma. In a forward-looking interview ...

India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for ...

Southampton Marrow student volunteers have recruited their 200,000th potential stem cell donor.

Scientists push CAR T cell therapy beyond blood cancers, unlocking potential for targeting solid tumors with enhanced delivery, resilience, and precision in the face of tough obstacles. Study: Beyond ...

Single-cell transcriptomics data from mouse bone-relevant cells was used to inform human bone mineral density genome-wide association studies and prioritize genetic targets with potential causal roles ...

The landscape of lupus treatment is rapidly evolving, bringing promising options such as CAR cell therapy and T-cell engager therapies. However, many individuals living with lupus, their caregivers, ...